CN1075376C - 滴鼻剂 - Google Patents

滴鼻剂 Download PDF

Info

Publication number
CN1075376C
CN1075376C CN98118205A CN98118205A CN1075376C CN 1075376 C CN1075376 C CN 1075376C CN 98118205 A CN98118205 A CN 98118205A CN 98118205 A CN98118205 A CN 98118205A CN 1075376 C CN1075376 C CN 1075376C
Authority
CN
China
Prior art keywords
gram
quinolones
present
nasal drop
nose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98118205A
Other languages
English (en)
Other versions
CN1208617A (zh
Inventor
刘文通
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98118205A priority Critical patent/CN1075376C/zh
Publication of CN1208617A publication Critical patent/CN1208617A/zh
Application granted granted Critical
Publication of CN1075376C publication Critical patent/CN1075376C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种滴鼻剂,在每10毫升生理盐水或蒸馏水中加入盐酸麻黄碱0.01-0.08克,喹诺酮类药物0.01-0.3克,肾上腺皮质激素药物0.005-0.02克,可在改善鼻通气的同时,进行抗菌、消炎、抗过敏,有效减轻鼻腔水肿,进而达到综合治愈之目的,经1000多例临床证明,总有效率达95%以上。

Description

滴鼻剂
本发明涉及到一种鼻炎用药,特别是一种滴鼻剂。
市场上有售多种用于治疗鼻炎的药物,如盐酸麻黄碱滴鼻液,可使血管收缩而改善鼻通气,但不能适症治疗,由于浓度达1%,而容易引起药物性鼻炎,就发明人所知目前还没有哪一种药物既可有效改善鼻通气,又具有广谱抗菌作用,同时又可抗过敏,减轻鼻腔水肿,并且副作用又少。
本发明的目的在于提供一种既可有效改善鼻通气,具有广谱抗菌作用,又抗过敏,减轻水肿,副作用不大的可综合适治新型滴鼻药。
本发明的目的是这样实现的:一种滴鼻剂,在每10毫升生理盐水或蒸馏水中含有盐酸麻黄碱0.01至0.08克,喹诺酮类药物0.01至0.3克,肾上腺皮质激素药物0.005至0.02克。
本发明所述喹诺酮类药物进一步来说为诺氟沙星或环丙沙星或氧氟沙星。
本发明肾上腺皮质激素类药物为氟美松。
本发明采用三种药物配伍,采用综合适治的办法从而达到了发明目的:由于采用了较少量的盐酸麻黄碱来收缩血管,从而可以达到既改善鼻通气,又温和持久,不易引发药物性鼻炎的作用;由于采用了喹诺酮类广普抗菌药物如诺氟沙星,可在收缩血管作用的同时对鼻腔内的细菌起到杀灭抑制作用;肾上腺皮质类药物具有抗过敏,减轻水肿的作用;本发明成份的适量有机组合,既改善了鼻腔通气,促进鼻窦引流,又减轻了鼻腔水肿,同时抗菌药物直接作用局部可有效杀灭细菌,治愈炎症,本发明经1000多例临床观察总有效率达95%以上。
以下通过实施例对本发明进行更为细致的描述:
实施例1:
在每10毫升生理盐水中加入盐酸麻黄碱0.02克,诺氟沙星0.08克,氟美松0.01克,溶解混匀,装入普通滴鼻剂瓶中即可,用法:每日滴鼻3次,每次3-5滴。可用于急、慢性化脓型上颌窦炎、急慢性鼻炎、过敏性鼻炎、感冒后鼻塞、流浓涕等。
实施例2:
在每10毫升蒸馏水中加入盐酸麻黄碱0.08克,环丙沙星或氧氟沙星0.1克,氟美松0.05克。

Claims (3)

1.一种滴鼻剂,其特征在于:在每10毫升生理盐水或蒸馏水中含有盐酸麻黄碱0.01至0.08克,喹诺酮类药物0.01-0.3克,肾上腺皮质激素药物0.005-0.02克。
2.根据权利要求1所述的滴鼻剂,其特征在于所述喹诺酮类药物为诺氧沙星或环丙沙星或氧氟沙星。
3.根据权利要求1或2所述的滴鼻剂,其特征在于肾上腺皮质激素类药物为氟美松。
CN98118205A 1998-08-30 1998-08-30 滴鼻剂 Expired - Fee Related CN1075376C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98118205A CN1075376C (zh) 1998-08-30 1998-08-30 滴鼻剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98118205A CN1075376C (zh) 1998-08-30 1998-08-30 滴鼻剂

Publications (2)

Publication Number Publication Date
CN1208617A CN1208617A (zh) 1999-02-24
CN1075376C true CN1075376C (zh) 2001-11-28

Family

ID=5225962

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98118205A Expired - Fee Related CN1075376C (zh) 1998-08-30 1998-08-30 滴鼻剂

Country Status (1)

Country Link
CN (1) CN1075376C (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105168119A (zh) * 2015-10-28 2015-12-23 周胜光 一种治疗鼻炎的复方滴鼻用凝胶制剂

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《新医学》"氧氟沙星、***滴耳液治疗慢性单纯型化脓性中耳" 1995.6.26 唐永元等;《药学实践杂志》,"鼻净滴剂 的制备及应用" 1996.5.14 陈伟成等 *
《新医学》"氧氟沙星、***滴耳液治疗慢性单纯型化脓性中耳" 1995.6.26 唐永元等 *
《药学实践杂志》,"鼻净滴剂 的制备及应用" 1996.5.14 陈伟成等 *

Also Published As

Publication number Publication date
CN1208617A (zh) 1999-02-24

Similar Documents

Publication Publication Date Title
US8758816B2 (en) Compositions comprising azelastine and methods of use thereof
RU2019111715A (ru) Окисляющие аммиак микроорганизмы для применения и доставки в интраназальной системе
US20040053902A1 (en) Novel composition and method for treatment of upper respiratory conditions
WO2004105731A8 (en) Nasal formulations including a topical decongestant and a topical corticosteroid and their use in treatment of obstructive sleep apnea
WO2004105702A3 (en) Foamable pharmaceutical compositions and methods for treating a disorder
AU2013305569A1 (en) Composition for the treatment of migraine headaches
EP3307293B1 (en) Formulations for the treatment of disorders of the mouth, throat and respiratory tract
KR20120046215A (ko) 소아를 위한 올로파타딘 비강 스프레이 요법
JP2017527608A (ja) 経鼻組成物と該経鼻組成物の使用方法の改善
CN102292099A (zh) 在鼻炎治疗中使用的重组人cc10及其组合物
Cortés et al. Executive summary of outpatient parenteral antimicrobial therapy: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases and the Spanish Domiciliary Hospitalisation Society
CN1075376C (zh) 滴鼻剂
WO2006029487A8 (en) Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis
WO2015122999A1 (en) Nasal and sinus wash compositions and methods
CN104971349B (zh) 一种外用复方制剂
CN103202881A (zh) 一种治疗皮疹的外用剂组合物
CN1115245A (zh) 防治感冒喷剂及其制备方法
CN101396368B (zh) 异甘草酸或其盐在制备治疗过敏性鼻炎药物中的应用
CN1222351A (zh) 复方滴鼻液
CN1989993A (zh) 特效防脱发搽剂
Yagudina et al. MARKET REVIEW OF MEDICINES USED IN THE TREATMENT OF HEMOPHILIA UNDER THE FEDERAL PROGRAM" 7 NOSOLOGIES"
Moon Once-Daily Corticosteroids for Mild, Persistent Asthma
CN1378842A (zh) 一种治疗皮肤病的药膏
CN1230180C (zh) 灭杀抑制真菌的外用药
Philpott Health focus: Skincare: Getting under the skin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee